Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction

Abstract Angiotensin receptor-neprilysin inhibitor (ARNI) and sodium–glucose co-transporter-2 inhibitor (SGLT2i) have shown benefits in diabetic patients with heart failure with reduced ejection fraction (HFrEF). However, their combined effect has not been revealed. We retrospectively identified dia...

Full description

Saved in:
Bibliographic Details
Main Authors: Hyue Mee Kim, In-Chang Hwang, Wonsuk Choi, Yeonyee E. Yoon, Goo-Yeong Cho
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/d10ce0ec93124a50a5d63f4f2bb7bdbe
Tags: Add Tag
No Tags, Be the first to tag this record!